Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum China Health Labs & Diagnostics Ltd CHLBF

GREY:CHLBF - Post Discussion

China Health Labs & Diagnostics Ltd > China Health Hires Strategic IR rep
View:
Post by marketman3 on Sep 09, 2011 1:37pm

China Health Hires Strategic IR rep

9/2011 9:00 AM - Canada NewsWire

TORONTO, Sep. 9, 2011, 2011 (Canada NewsWire via COMTEX News Network) --
TSX-V:CHO OTCQX:CHLBF

China Health Labs & Diagnostics Ltd. ("China Health" or the "Company") (TSXV: CHO) (OTCQX: CHLBF) is pleased to announce that it has engaged Langda Consulting ("Langda") to provide China Health with strategic investor relations services focused on communities and investors that have an interest in China-based companies. Langda will work in collaboration with TMX Equicom to deliver the Company's investor relations program.

Langda is a Toronto based consulting firm specializing in providing professional consulting services to China-based companies in raising capital, developing investment opportunities and increasing market awareness in Canada and the United States. Under the terms of the consulting services agreement, China Health will pay Langda a monthly fee of $3,600 plus HST for such services for an initial term of six months.

Neither Langda nor any of its principals have an ownership interest, directly or indirectly, in China Health or its securities, nor has the Company granted Langda or its principals any rights or options to acquire any such interests.

About China Health Labs & Diagnostics Ltd.

Comment by TerryPandi on Sep 09, 2011 3:13pm
How hard will the new IR work when they don't even get options for the deal??  Not impressed with how the market has been mismanaged considering the good news releases.  No bid support whatsoever!  Somebody bring back the IR that took this to $1.50
Comment by TheRock07 on Sep 10, 2011 7:14am
I think this is a good move , as Langda will work in collaboration with CHO's other IR rep ( TMX Equicom was hired in Aug 2011  ) to deliver the message to communities and investors that have an interest in China-based companies.I presume this means, in part, the large Chinese communities in Canada and the US.So, CHO now have added a second IR rep that also specializes  raising ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities